Description
Recombinant monoclonal antibody to VEGF. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the therapeutic antibody Bevacizumab. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
Target
VEGF
Target Alias Names
ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression